期刊文献+

神经生长因子巩膜外缓释给药的研究 被引量:1

Experimental study on directional control-released delivery of NGF through sclera
下载PDF
导出
摘要 目的探讨巩膜外植入神经生长因子(NGF)药膜后其眼内的药代动力学改变,研究该药膜是否有缓释效果,改善NGF给药途径。方法筛选与NGF有亲和力的胶原组织,制成具有单向缓释功能的药膜,将其植入健康白兔巩膜表面,朋ELISA法测定并观察对照组和实验组各时间点玻璃体内NGF质量浓度的变化,用3P97药代动力学程序计算主要药代动力学参数。结果实验组在药膜植入后2~15d内NGF质量浓度明显高于对照组,第18d降至正常。第3d达到峰质量浓度20.911g/ml,半衰期约7.41d。药一时曲线下面积AUC0-18为232.78801ng·d/ml。结论自制NGF药膜可缓释进入玻璃体,其峰浓度较高,消除半衰期较长,质量浓度波动较小. Objective Nerve growth factor (NGF) is protein neurotrophic factor and it is difficult to topically use in ophthahnology. Our experiment observed the intravitreal pharmacokineties of control-released NGF drug membrane implanted into the subconjunctiva and outside the sclera of the rabbits and investigated the slow release ability of NGF drug membrane. Methods Sixty rabbits were divided into ten groups,and 6 rabbits were selected randomly as the control group. Unidirectional NGF-collagen control-released membranes were prepared and embedded beneath the inferior rectus muscle in the right eyes of rabbits from 9 experimental groups. Rabbit vitreous specimen were obtained in 2,3,6,8,9, 11, 12, 15 and 18 days after experiment. NGF concentratinn alteration in vitreous were measured by BAS-ELISA method and the pharmacnkinetie change was computed by 3P97 software. Results NGF level in vitreous body was decreased slowly with time lapse in experimental groups, and the NGF concentrations in vitreous within 2 - 15 days were higher than that of control group. The NGF level decreased to normal on the 18th day. The maximum concentration of NGF in experimental groups was 20.91 ng/rid on the 3rd day. The half-life for elimination(t1/2) of NGF from vitreous was about 7.41 days. The area under concentration-time eurve(AUC0-t) was 232. 788 01 ng · d/ml. Conclusion The NGF-collagen control-released membranes are able to release NGF regularly and penetrate the wall of eyeball into the intraocular tissue and accumulate in vitreous body. It has a higher Cmax and longer half-life. The NGF concentration in vitreous decline with less fluctuation.
出处 《眼科研究》 CSCD 北大核心 2006年第6期589-592,共4页 Chinese Ophthalmic Research
关键词 神经生长因子 缓释药膜 玻璃体 药代动力学 nerve growth factor control-released drug membrane vitreous pharmacokinetics
  • 相关文献

参考文献7

  • 1Amendola T,Aloe L.Developmental expression of nerve growth factor in the eye of rats affected by inherited retinopathy:correlative aspects with retinal structural degeneration[J].Arch Ital Biol,2002,140(2):81-90
  • 2Karlsson M,Mayordomo R.Nerve growth factor is expressed by postmitotic avian retinal horizontal cells and supports their survival during development in an autocrine mode of action[J].Development,2001,128(4):471-479
  • 3Tomita H,Ishiguro S,Abe T,et al.Increased expression of low-affinity NGF receptor in rat retinal Müller cells after ischemia and reperfusion[J].Cell Struct Funct,1998,23(4):201-207
  • 4Lambiase A,Centofanti M,Micera A,et al.Nerve growth factor (NGF) reduces and NGF antibody exacerbates retinal damage induced in rabbit by experimental ocular hypertension[J].Graefes Arch Clin Exp Ophthalmol,1997,235(12):780-785
  • 5Lambiase A,Aloe L.Nerve growth factor delays retinal degeneration in C3H mice[J].Graefes Arch Clin Exp Ophthalmol,1996,234 (1):96-100
  • 6蒋永祥.神经生长因子细胞保护作用的应用研究进展[J].眼科研究,2002,20(1):83-85. 被引量:8
  • 7朱冉.神经生长因子在伴有基质溶解免疫性角膜溃疡中的抗炎和愈合性能[J].美国医学会眼科杂志(中文版),2001,13(2):110-112. 被引量:1

二级参考文献1

共引文献7

同被引文献22

  • 1王理理,黄振平,刘玉秀,张丽京,潘丽娟,杨建东,王林农.噻吗洛尔眼用凝胶液临床应用观察[J].医学研究生学报,2005,18(6):529-532. 被引量:1
  • 2张惠成,胡勇平,陈滨,董映,项燕.原发性闭角型青光眼毛果芸香碱脂质体治疗的研究[J].中国现代应用药学,2006,23(1):3-7. 被引量:6
  • 3郑晓丽,王广慧,魏淑芳,高建鲁,李镜海.丝裂霉素C缓释系统辅助兔青光眼滤过性手术的研究[J].眼科研究,2007,25(7):498-501. 被引量:2
  • 4Schmier JK,Covert DW,Lau EC,et al.Trends in annual medicare expenditures for glaucoma surgical procedures from1997to2006.Arch Ophthalmol2009;127(7):900-905.
  • 5Macoul KL,Pavan-Langston D.Pilocarpine ocusert system for sustained control of ocular hypertension.Arch Ophthalmol1975;93(8):587-590.
  • 6Pollack IP,Quigley HA,Harbin TS.Ocusert pilocarpine systemadvantages and disadvantages.South Med1976;69(10):1296-1298.
  • 7Saettone MF,Salminen L.Ocular inserts for topical delivery.Adv Drug Deliv Rev1995;16(1):95-106.
  • 8Huang SF,Chen JL,Yeh MK,et al.Physicochemical properties and in vivo assessment of timolol-loaded poly(D,L-lactide-co-glycolide)films for long-term intraocular pressure lowering effects.J Ocul Pharmacol Ther2005;21(6):445-453.
  • 9Paulsson M,Hgerstrm H,Edsman K.Rheological studies of the gelation of deacetylated gellan gum(Gelrite)in physiological conditions.Eur J Pharm Sci1999;9(1):99-105.
  • 10Bhaskaran S,Lakshmi PK,Harish CG.Topical ocular drug deliverya review.Ind J Pharm Sci 2005;67(4):404-408.

引证文献1

二级引证文献5

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部